
IDEXX Laboratories IDXX
$ 675.24
-2.1%
IDEXX Laboratories ROA Ratio | IDXX
Annual ROA Ratio IDEXX Laboratories
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31.62 | 26.96 | 25.92 | 24.72 | 30.56 | 25.35 | 23.34 | 24.52 | 15.36 | 14.51 | 13.02 | 13.14 | 15.26 | 16.15 | 15.69 | 15.75 | 15.12 | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 31.62 | 13.02 | 20.41 |
Quarterly ROA Ratio IDEXX Laboratories
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q4 | 2010-Q3 | 2010-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 34.02 | 33.57 | 32.57 | 31.89 | 31.05 | 29.89 | 27.02 | 26.49 | 25.89 | 25.82 | 27.68 | 28.28 | 28.58 | 28.56 | 25.81 | 25.67 | 26.08 | 26.56 | 29.9 | 31.2 | 32.14 | 31.95 | 31.15 | 28.3 | 25.61 | 24.68 | 24.37 | 24.55 | 25.18 | 25.04 | 24.89 | 24.87 | 21.53 | 19.69 | 17.76 | 16.07 | 17.25 | 16.79 | 16.09 | 14.81 | 14.39 | 13.63 | 12.97 | 13.11 | 11.98 | 13.03 | 13.63 | 14.07 | 15.71 | 15.49 | 15.67 | 15.94 | 16.35 | 16.45 | 16.62 | 16.5 | 16.26 | 16.31 | 16.62 | 16.8 | 17.17 | 17.22 | 16.57 | 4.05 | 4.03 | 4.46 |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 34.02 | 4.03 | 21.28 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | ||
|
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | ||
|
Renalytix AI plc
RNLX
|
-419.67 | - | 5.66 % | $ 22.7 M | ||
|
Meridian Bioscience
VIVO
|
9.17 | - | - | $ 1.49 B | ||
|
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | ||
|
Accelerate Diagnostics
AXDX
|
-175.25 | - | -61.36 % | $ 2.46 M | ||
|
T2 Biosystems
TTOO
|
-143.91 | - | -39.35 % | $ 313 K | ||
|
Syneos Health
SYNH
|
3.25 | - | - | $ 4.46 B | ||
|
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | ||
|
Invitae Corporation
NVTA
|
-5.11 | - | - | $ 21.2 M | ||
|
Quotient Limited
QTNT
|
-64.5 | - | -11.32 % | $ 1.1 M | ||
|
Brainsway Ltd.
BWAY
|
3.1 | $ 8.53 | -2.29 % | $ 290 M | ||
|
Burning Rock Biotech Limited
BNR
|
-6.75 | $ 13.46 | 1.05 % | $ 142 M | ||
|
Medpace Holdings
MEDP
|
22.84 | $ 609.81 | -3.81 % | $ 17.6 B | ||
|
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | ||
|
Surmodics
SRDX
|
-6.46 | - | - | $ 608 M | ||
|
RadNet
RDNT
|
-0.5 | $ 69.77 | 0.37 % | $ 5.25 B | ||
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M | ||
|
Psychemedics Corporation
PMD
|
-22.37 | - | -1.84 % | $ 15.3 M | ||
|
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | ||
|
Biodesix
BDSX
|
-40.31 | $ 7.55 | -9.1 % | $ 57 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | ||
|
Agilent Technologies
A
|
10.24 | $ 169.82 | -3.21 % | $ 48.2 B | ||
|
Charles River Laboratories International
CRL
|
-2.02 | $ 314.38 | -4.13 % | $ 15.6 B | ||
|
Quest Diagnostics Incorporated
DGX
|
6.11 | $ 257.78 | -0.4 % | $ 28.6 B | ||
|
Danaher Corporation
DHR
|
4.33 | $ 220.3 | -3.19 % | $ 157 B | ||
|
DexCom
DXCM
|
13.19 | $ 79.02 | -1.46 % | $ 30.8 B | ||
|
Anixa Biosciences
ANIX
|
-67.95 | $ 2.44 | -6.15 % | $ 79.2 K | ||
|
Celcuity
CELC
|
-37.95 | $ 53.32 | -5.31 % | $ 2.49 B | ||
|
Guardant Health
GH
|
-20.67 | $ 145.9 | 0.21 % | $ 18.3 B | ||
|
BioNano Genomics
BNGO
|
-35.87 | $ 0.82 | -7.56 % | $ 4.46 M | ||
|
Bioventus
BVS
|
3.33 | $ 9.89 | -0.65 % | $ 659 M | ||
|
IQVIA Holdings
IQV
|
4.54 | $ 245.67 | -1.92 % | $ 42.2 B | ||
|
Laboratory Corporation of America Holdings
LH
|
4.77 | $ 367.68 | -0.44 % | $ 30.6 B | ||
|
Castle Biosciences
CSTL
|
-4.18 | $ 32.69 | -2.14 % | $ 948 M | ||
|
Mettler-Toledo International
MTD
|
23.41 | $ 1 667.59 | -2.3 % | $ 34.4 B | ||
|
Illumina
ILMN
|
12.79 | $ 192.79 | -3.92 % | $ 29.9 B | ||
|
Natera
NTRA
|
-8.68 | $ 273.11 | -5.8 % | $ 37.3 B | ||
|
Koninklijke Philips N.V.
PHG
|
3.33 | $ 28.63 | -2.22 % | $ 27.1 B | ||
|
Fulgent Genetics
FLGT
|
-4.99 | $ 24.03 | -3.03 % | $ 740 M | ||
|
CareDx, Inc
CDNA
|
-5.17 | $ 69.9 | -2.81 % | $ 3.72 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M | ||
|
Biomerica
BMRA
|
-55.85 | $ 1.09 | -0.46 % | $ 3.18 M | ||
|
Interpace Biosciences
IDXG
|
72.7 | $ 4.4 | -4.35 % | $ 19.5 M | ||
|
Lantheus Holdings
LNTH
|
10.49 | $ 102.12 | 0.01 % | $ 6.89 B | ||
|
Senseonics Holdings
SENS
|
-54.72 | $ 8.03 | -9.88 % | $ 335 M | ||
|
Sotera Health Company
SHC
|
2.39 | $ 15.92 | -1.82 % | $ 4.52 B | ||
|
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | ||
|
ICON Public Limited Company
ICLR
|
1.41 | $ 186.79 | -1.88 % | $ 14.6 B |